142 related articles for article (PubMed ID: 27683117)
21. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
22. Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells.
Kam AY; Tse TT; Kwan DH; Wong YH
Cell Signal; 2007 Oct; 19(10):2106-17. PubMed ID: 17643960
[TBL] [Abstract][Full Text] [Related]
23. Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome.
Pacey LK; Doering LC
Glia; 2007 Nov; 55(15):1601-9. PubMed ID: 17823967
[TBL] [Abstract][Full Text] [Related]
24. Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome.
Lessard M; Chouiali A; Drouin R; Sébire G; Corbin F
Clin Genet; 2012 Nov; 82(5):472-7. PubMed ID: 21992468
[TBL] [Abstract][Full Text] [Related]
25. Linking the Fragile X mental retardation protein to the lipoxygenase pathway.
Beaulieu MA
Med Hypotheses; 2013 Mar; 80(3):289-91. PubMed ID: 23313071
[TBL] [Abstract][Full Text] [Related]
26. The targeting and functions of miRNA-383 are mediated by FMRP during spermatogenesis.
Tian H; Cao YX; Zhang XS; Liao WP; Yi YH; Lian J; Liu L; Huang HL; Liu WJ; Yin MM; Liang M; Shan G; Sun F
Cell Death Dis; 2013 May; 4(5):e617. PubMed ID: 23640459
[TBL] [Abstract][Full Text] [Related]
27. Elevated progranulin contributes to synaptic and learning deficit due to loss of fragile X mental retardation protein.
Zhang K; Li YJ; Guo Y; Zheng KY; Yang Q; Yang L; Wang XS; Song Q; Chen T; Zhuo M; Zhao MG
Brain; 2017 Dec; 140(12):3215-3232. PubMed ID: 29096020
[TBL] [Abstract][Full Text] [Related]
28. FMRP expression as a potential prognostic indicator in fragile X syndrome.
Tassone F; Hagerman RJ; Iklé DN; Dyer PN; Lampe M; Willemsen R; Oostra BA; Taylor AK
Am J Med Genet; 1999 May; 84(3):250-61. PubMed ID: 10331602
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
Karam M; Legay C; Auclair C; Ricort JM
Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
[TBL] [Abstract][Full Text] [Related]
30. The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.
Zalfa F; Panasiti V; Carotti S; Zingariello M; Perrone G; Sancillo L; Pacini L; Luciani F; Roberti V; D'Amico S; Coppola R; Abate SO; Rana RA; De Luca A; Fiers M; Melocchi V; Bianchi F; Farace MG; Achsel T; Marine JC; Morini S; Bagni C
Cell Death Dis; 2017 Nov; 8(11):e3169. PubMed ID: 29144507
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
32. Myosin Va is required for the transport of fragile X mental retardation protein (FMRP) granules.
Lindsay AJ; McCaffrey MW
Biol Cell; 2014 Feb; 106(2):57-71. PubMed ID: 24175909
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of Fragile X mental retardation protein in malformative lesions of patients with focal cortical dysplasia.
Reynolds CD; Nolan SO; Smith GD; Jefferson TS; Hodges SL; Brewster AL; Lugo JN
Neuroreport; 2020 Oct; 31(14):1036-1041. PubMed ID: 32833881
[TBL] [Abstract][Full Text] [Related]
34. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Equivalence between Two Commercially Available S499-Phosphorylated FMRP Antibodies in Mice.
Reynolds CD; Smith GD; Jefferson TS; Lugo JN
PLoS One; 2015; 10(11):e0143134. PubMed ID: 26580204
[TBL] [Abstract][Full Text] [Related]
36. Markers of mRNA stabilization and degradation, and RNAi within astrocytoma GW bodies.
Moser JJ; Eystathioy T; Chan EK; Fritzler MJ
J Neurosci Res; 2007 Dec; 85(16):3619-31. PubMed ID: 17663465
[TBL] [Abstract][Full Text] [Related]
37. Fragile X mental retardation protein regulates olfactory sensitivity but not odorant discrimination.
Schilit Nitenson A; Stackpole EE; Truszkowski TL; Midroit M; Fallon JR; Bath KG
Chem Senses; 2015 Jun; 40(5):345-50. PubMed ID: 25917509
[TBL] [Abstract][Full Text] [Related]
38. MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome.
Li Y; Stockton ME; Bhuiyan I; Eisinger BE; Gao Y; Miller JL; Bhattacharyya A; Zhao X
Sci Transl Med; 2016 Apr; 8(336):336ra61. PubMed ID: 27122614
[TBL] [Abstract][Full Text] [Related]
39. Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance.
Antonelli M; Massimino M; Morra I; Garrè ML; Gardiman MP; Buttarelli FR; Arcella A; Giangaspero F
Neuropathology; 2012 Apr; 32(2):133-8. PubMed ID: 21978279
[TBL] [Abstract][Full Text] [Related]
40. [Hair root fragile X mental retardation protein assay for the diagnosis of fragile X syndrome].
Luo XF; Zhong JM; Zhang XZ; Zou Y; Chen Y; Wu HP; Yu XY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):817-20. PubMed ID: 19849940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
